Genmab AS

Genmab AS Net Change in Cash

The Net Change in Cash of Genmab AS (GMAB) as of Nov 22, 2026 is 345.33 M USD. In the previous year, Net Change in Cash was -5.01 B USD — a change of -106.89% (higher).

Net Change in Cash

345.33 MUSD

YoY

-106.89%

Last updated:

Net Change in Cash of Genmab AS is 2025 345.33 M USD. Net Change in Cash of Genmab AS was 2024 -5.01 B USD. It decreases by -106.89% higher compared to the previous year.

The Genmab AS Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
-814.64 M USD
Jan 1, 2019
3.02 B USD
Jan 1, 2020
3.71 B USD
Jan 1, 2021
1.70 B USD
Jan 1, 2022
936.00 M USD
Jan 1, 2023
4.97 B USD
Jan 1, 2024
-5.01 B USD
Jan 1, 2025
345.33 M USD
The Genmab AS Net Change in Cash history
YEARNet Change in CashYoY
345.33 MUSD-106.89%
-5.01 BUSD-200.70%
4.97 BUSD+431.41%
936.00 MUSD-44.84%
1.70 BUSD-54.23%
3.71 BUSD+22.82%
3.02 BUSD-470.59%
-814.64 MUSD-178.29%
1.04 BUSD-283.53%
-566.96 MUSD-210.11%
514.90 MUSD+169.65%
190.95 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

Net Change in Cash of Genmab AS is 345.33 M USD in 2025.

Net Change in Cash of Genmab AS changed from -5.01 B USD to 345.33 M USD, representing a -106.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Genmab AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Genmab AS

All Key Metrics — Genmab AS